Literature DB >> 31612839

Intravenous Lidocaine for Relief of Chronic Neuropathic Pain.

Kathleen Wren1, Rachelle J Lancaster1, MacKenzie Walesh2, Kristen Margelosky2, Karen Leavitt3, Amy Hudson4, Maurizio Z Albala5.   

Abstract

The purpose of this study was to describe the therapeutic effectiveness/pain relief of moderate-dose lidocaine infusions in patients with chronic neuropathic pain. Retrospective reviews of medical records were conducted for 40 patients referred to a midwestern pain clinic for management of intractable neuropathic pain despite use of multiple medications and treatment modalities. Descriptive statistics were used to summarize patients' demographic data, lidocaine dosing and infusion rate, daily opioid intake, adjuvant medication use, and medication allergies and intolerances. Paired samples t test was used to determine significance between preinfusion and postinfusion pain scores. A significant decrease in pain levels (P < .001) after infusion was found. Copyright© by the American Association of Nurse Anesthetists.

Entities:  

Keywords:  Chronic neuropathic pain; intravenous lidocaine; morphine milligram equivalent dose

Mesh:

Substances:

Year:  2019        PMID: 31612839

Source DB:  PubMed          Journal:  AANA J        ISSN: 0094-6354


  3 in total

Review 1.  Current Strategies for the Management of Painful Diabetic Neuropathy.

Authors:  Michael D Staudt; Tarun Prabhala; Breanna L Sheldon; Nicholas Quaranta; Michael Zakher; Ravneet Bhullar; Julie G Pilitsis; Charles E Argoff
Journal:  J Diabetes Sci Technol       Date:  2020-08-28

2.  Lidocaine infusions in chronic pain management: A prospective case series analysis.

Authors:  Elizabeth Vacher; Monika Kosela; Charlie Song-Smith; Fausto Morell-Ducos; Alan Fayaz
Journal:  Br J Pain       Date:  2021-11-22

Review 3.  Intravenous Lidocaine Infusion for the Management of Early Postoperative Pain: A Comprehensive Review of Controlled Trials.

Authors:  Robert Chu; Nelly Umukoro; Tiashi Greer; Jacob Roberts; Peju Adekoya; Charles A Odonkor; Jonathan M Hagedorn; Dare Olatoye; Ivan Urits; Mariam Salisu Orhurhu; Peter Umukoro; Omar Viswanath; Jamal Hasoon; Alan D Kaye; Vwaire Orhurhu
Journal:  Psychopharmacol Bull       Date:  2020-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.